Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Glabellar Lines”

82 trials

Showing 20 of 82 results

Testing effectiveness (Phase 2)Study completedNCT04996810
What this trial is testing

The Safety and Efficacy Study of PROTOXIN in Subjects With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Protox Inc. 60
Early research (Phase 1)Study completedNCT04944953
What this trial is testing

To Compare the Safety and Efficacy of "HG-102" With Botox® in the Improvement of Moderate to Severe Glabellar Lines.

Who this might be right for
Glabellar Lines
Hugel 38
Large-scale testing (Phase 3)Active Not RecruitingNCT06583486
What this trial is testing

A Study on the Efficacy and Safety of Repeated Treatments With Recombinant Botulinum Toxin Type A for Injection in the Treatment of Moderate to Severe Glabellar Lines

Who this might be right for
Moderate to Severe Glabellar Lines
Chongqing Claruvis Pharmaceutical Co., Ltd. 488
Large-scale testing (Phase 3)Study completedNCT05380154
What this trial is testing

Efficacy and Safety Assessment of Botulax® and BOTOX® for Improvement of Glabellar Lines.

Who this might be right for
Glabellar Lines
Hugel 500
Large-scale testing (Phase 3)Study completedNCT05463965
What this trial is testing

Evaluate the Efficacy and Safety of QM1114-DP for the Treatment of Moderate to Severe Glabellar Lines

Who this might be right for
Moderate to Severe Glabellar Lines
Galderma R&D 605
Large-scale testing (Phase 3)Study completedNCT03216408
What this trial is testing

Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Lines
Medy-Tox 504
Post-approval studies (Phase 4)Study completedNCT03687736
What this trial is testing

Subject Satisfaction With AbobutulinumtoxinA Treatment

Who this might be right for
Glabellar Frown Lines
Galderma R&D 120
Large-scale testing (Phase 3)Study completedNCT03960957
What this trial is testing

Efficacy and Safety of a New Dilution and Injection Volume of AbobotulinumtoxinA for the Treatment of Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Galderma R&D 301
Testing effectiveness (Phase 2)Study completedNCT02184988
What this trial is testing

Safety Study of DWP-450 (Botulinum Purified Neurotoxin, Type A) Injection to Treat Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Evolus, Inc. 352
Large-scale testing (Phase 3)Study completedNCT01791920
What this trial is testing

To Evaluate the Safety and Efficacy of Botulax® Are Not Inferior to Those of Botox® in the Treatment of Glabellar Lines

Who this might be right for
Skin Aging
Hugel 262
Testing effectiveness (Phase 2)Study completedNCT05743634
What this trial is testing

A Phase I/II Study of Recombinant Botulinum Toxin Type A for the Treatment of Moderate to Severe Glabellar Lines

Who this might be right for
Moderate to Severe Glabellar Lines
Chongqing Claruvis Pharmaceutical Co., Ltd. 140
Very early researchUnknownNCT05305768
What this trial is testing

Xeomin Treatment of Glabellar Lines Using OLD Versus COLD

Who this might be right for
Glabellar Frown Lines
Clinical Testing of Beverly Hills 40
Large-scale testing (Phase 3)UnknownNCT03440671
What this trial is testing

The Safety and Efficacy Study of Hutox Versus Botox® in Subject With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Huons Co., Ltd. 260
Testing effectiveness (Phase 2)Study completedNCT05217355
What this trial is testing

A Phase II Study to Evaluate the Efficacy and Safety of MBA-P01 in Subjects With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Medytox Korea 50
Testing effectiveness (Phase 2)Study completedNCT02428608
What this trial is testing

Safety Study of DWP-450 (Botulinum Toxin, Type a) to Treat Glabellar Lines - EV-006

Who this might be right for
Glabellar Frown Lines
Evolus, Inc. 570
Post-approval studies (Phase 4)Study completedNCT01391312
What this trial is testing

Patient Satisfaction Study of BOTOX® Cosmetic in the Treatment of Moderate to Severe Frown Lines

Who this might be right for
Glabellar Frown Lines
Allergan 40
Testing effectiveness (Phase 2)Study completedNCT01485601
What this trial is testing

Safety and Efficacy Study of Botulinum Toxin Type A to Treat Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Medy-Tox 121
Large-scale testing (Phase 3)Study completedNCT06946160
What this trial is testing

A Non-inferiority Clinical Trial to Compare Efficacy and Safety of Abobotulinumtoxin A (Espad Pharmed) Versus AbobotulinumtoxinA (Dysport®, Ipsen Co.) for Correction of Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar LinesGlabellar Frown Lines
Espad Pharmed 146
Large-scale testing (Phase 3)Study completedNCT05531968
What this trial is testing

Treatment of Moderate to Severe Glabellar Lines (BMI2006)

Who this might be right for
Glabellar Lines
BMI Korea 278
Large-scale testing (Phase 3)Study completedNCT05364580
What this trial is testing

The Efficacy and Safety Study of Protoxin Versus Botox® in Subjects With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Protox Inc. 269
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation